Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 3119-3122

  Runic, Radmila ^a   Lockwood, Charles J ^a   Ma, Yuehong ^a   Dipasquale, Bruno ^a   Guller, Seth ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL INVASION; CYTOLYSIS; CYTOTROPHOBLAST; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; REPRODUCTION;

ANTIGENS, SURFACE; BLOTTING, WESTERN; FAS LIGAND PROTEIN; FEMALE; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; PLACENTA; PREGNANCY; TISSUE DISTRIBUTION; TROPHOBLASTS;

EID: 0029810376     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.3119     Document Type: Article

References (22)

1. Nagata S, Goldstein P (1995) The Fas death factor. Science 267:1449-1456.
2. Suda T, Takahashi T, Goldstein P, Nagata, S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
3. Griffith TS, Brunner T, Fletcher, SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192.
4. Bellgrau D, Gold D, Selawry H, et al. (1995) A role for CD95 in preventing graft rejection. Nature 377:630-632.
5. Roitt IM (1994) Transplantation. In: Essential Immunology, 8th ed. Blackwell Scientific Publications, Cambridge, pp 358-359.
6. Katz VL, Kuller JA (1994) Recurrent miscarriage. Am J Perinatol 11:386-397.
7. Lockwood CJ, Rand JH (1994) The immunobiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Surv 49:432-441.
8. Guller S, Wozniak R, Krikun G, et al. (1993) Glucocorticoid suppression of human placental fibronectin expression: implications in uterine-placental adherence. Endocrinology 133: 1139-1146.
9. Damsky CH, Fitzgerald ML, Fisher SJ (1992) Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasion pathway, in vivo. J Clin Invest 89:210-222.
10. Pritchard JA, MacDonald PA, Gant INF (1985) The placenta and fetal membranes. In: Williams' Obstetrics, 17 ed. Appleton-Century Crofts, Norwalk, pp 97-117.
11. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271:521-525.
12. Kayagaki N, Kawasaki A, Ebata T, et al. (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182:1777-1783.
13. Mariani SM, Matiba B, Bäumler C, Krammer PH (1995) Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteineases.
14. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss III, JF (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118:1567-1582.
15. Bulmer JN, Longfellow M, Ritson A (1991) Leukocytes and resident blood cells in endometrium. Ann NY Acad Sci 622:57-68.
16. King A, Loke YW (1993) Effect of IFN-gamma and IFN-alpha on killing of human trophoblasts by decidual LAK cells. J Reprod Immunol 23:51-62.
17. Hunt JS, Orr HT (1992) HLA and maternal-fetal recognition. FASEB J 6:2344-2348.
18. Steven DH (1983) Interspecies differences in the structure and function of trophoblast. In: Biology of Trophoblast. Loke YW, Whyte A, Eds. Elsevier, New York, pp 111-136.
19. Aplin JD (1991) Implantation, trophoblast differentiation, and haemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci 99:681-692.
20. Sakuragi N, Ishikura H, Hareyama H, et al. (1994) Apoptosis in human trophoblastic cells identified by in situ nick end labeling of fragmented DNA. Acta Obst Gynec Jpn 46:533-534.
21. Runić R, Lockwood CJ, LaChapelle L, et al. (1996) Apoptosis in human fetal membranes: implications in parturition-associated changes in fetal membrane integrity. J Soc Gynecol Invest 3:293A (Abstr.).
22. Lockwood CJ (1994) Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventive therapies. Curr Opin Ob Gyn 6:7-18.